Efgartigimod: A novel antibody depletion therapy in myasthenia gravis.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Guidon, AC; Juel, VC

Published Date

  • June 4, 2019

Published In

Volume / Issue

  • 92 / 23

Start / End Page

  • 1079 - 1080

PubMed ID

  • 31118243

Pubmed Central ID

  • 31118243

Electronic International Standard Serial Number (EISSN)

  • 1526-632X

Digital Object Identifier (DOI)

  • 10.1212/WNL.0000000000007605

Language

  • eng

Conference Location

  • United States